LIMRA, the Reinsurance Group of America (RGA), the Society of Actuaries (SOA) and TAI have collaborated on an ongoing effort to analyze the impact of COVID-19 on the individual life insurance industry’s mortality experience and share the emerging results with the insurance industry and the public.
Will the COVID-19 pandemic cause ‘diseases of despair’ to rise and will this affect long term trends in mortality and morbidity?
The U.S. hit a sad record in 2020, with deaths reaching more than 3 million for the first time.
Resting heart rate effectively segments mortality across age, gender and BMI, even when factoring in number of steps and hours slept.
COVID-19 Mortality by Age, Gender, Ethnicity, Obesity, and Other Risk Factors: A Comparison Against All-Cause Mortality
How much do different factors influence COVID-19 mortality risk versus all-cause mortality risk? RGA’s Global Data Insights team set out to answer this question through a thorough analysis and comparison of COVID-19 and all-cause mortality risk factors for the population of England.
Is diabetes more deadly for women and the young? Recent research, jointly undertaken by RGA and MIB, examines mortality and morbidity indicators for diabetics based, for the first time, on both MIB’s impairment records and RGA’s prescription drug history information.
Munich Re Life US recently evaluated mortality risk scores from the ExamOne HealthPiQture™ suite to assess their impact in segmenting mortality as part of the life insurance underwriting process.
Millions of overweight and obese individuals are at increased risk of non-communicable diseases and early mortality than the non-obese. RGA's Hilary Henly explores what insurers need to know about the consequences of rising obesity rates and dietary trends across the globe.
We must chart a course that continues producing robust mortality gains absolutely critical to our bottom lines … despite the challenges posed by the incipient 2020 Great Recession and the protean consequences of the COVID-19 pandemic. This article identifies and discusses core factors that I believe will determine how all of this sorts out over the next decade. It also suggests how we can greatly minimize mortality-related adversities via prudent changes in how we underwrite life insurance.
Mortality results are of paramount importance to your bottom line. Here, a seasoned industry expert explains what the current situation is, why we are where we are, and how we can survive.